$2.01
-0.02-0.99%
Last update: Oct 29, 3:31 PM
BioLine Rx Ltd
BLRXNASDAQ
BioLine Rx (BLRX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.24 | $-1.04 | $-0.54 | $-0.49 |
| Actual | $0.00 | $0.00 | $-0.34 | $-0.22 |
| Surprise | +100.0% | +100.0% | +37.0% | +55.1% |
| Revenue | ||||
| Estimate | $500000 | $343000 | $651598 | $606000 |
| Actual | $294000 | $477000 | $194000 | $427000 |
| Surprise | -41.2% | +39.1% | -70.2% | -29.5% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.69 | $-0.72 |
| Revenue | ||
| Consensus | $358000 | $492000 |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 31, 2026 | $0 | $-0.24 | 100.0 % |
| Q1 | May 27, 2026 | $0 | $-1.04 | 100.0 % |
| Q4 | Mar 23, 2026 | $-0.34 | $-0.54 | 37.0 % |
| Q3 | Nov 24, 2025 | $-0.22 | $-0.49 | 55.1 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 31, 2026 | $294.00K | $500.00K | -41.2 % |
| Q1 | May 27, 2026 | $477.00K | $343.00K | 39.1 % |
| Q4 | Mar 23, 2026 | $194.00K | $651.60K | -70.2 % |
| Q3 | Nov 24, 2025 | $427.00K | $606.00K | -29.5 % |
